Chemotherapy in Pregnancy: Assessing the Safety of Adriamycin Administration in Pregnancy Complicated by Breast Cancer

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Pregnancy-associated breast cancer is challenging to treat. Treatment with chemotherapeutic agents such as anthracyclines poses a risk of cardiotoxicity, despite being considered safe after the second trimester of pregnancy. Management requires multidisciplinary comanagement with cardio-obstetrics, cardiology-oncology, maternal-fetal medicine, and oncology.

Original languageEnglish (US)
Article number102141
JournalJACC: Case Reports
Volume28
DOIs
StatePublished - Dec 20 2023

Keywords

  • cancer
  • cardiomyopathy
  • pregnancy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Chemotherapy in Pregnancy: Assessing the Safety of Adriamycin Administration in Pregnancy Complicated by Breast Cancer'. Together they form a unique fingerprint.

Cite this